We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Kymera Therapeutics Inc | NASDAQ:KYMR | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -1.04 | -3.00% | 33.62 | 481,498 | 21:05:53 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 13.51 | 35.85 | 34.47 | 33.4784 | 34.13 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 78.59M | -146.96M | -2.4048 | -13.98 | 2.05B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 21:29:06 | average | 662 | 33.62 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 22/6/2023 | 14:21 | DJN | Kymera Therapeutics Gets Orphan-Drug Status for Leukemia Treatment |
Kymera Therapeutics (KYMR) Share Charts1 Year Kymera Therapeutics Chart |
|
1 Month Kymera Therapeutics Chart |
Intraday Kymera Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
